The use of Ozempic has been associated with gallbladder diseases such as gallstones (cholelithiasis) and inflammation of the gallbladder (cholecystitis). These Ozempic side effects can lead to gallbladder removal surgery (cholecystectomy). We are currently investigating certain Ozempic gallbladder cases as possible Ozempic drug injury lawsuits that would be filed against the responsible drug company, Novo Nordisk.
If you were prescribed Ozempic before April 2022 and had gallbladder removal surgery or were hospitalized for gallbladder disease, you should have an experienced drug injury lawyer review your possible Ozempic drug injury lawsuit.
As background, an Ozempic gallbladder disease warning was the subject of a March 2022 Ozempic drug label change by Novo Nordisk.
While this March 2022 Ozempic gallbladder label change is a significant part of the legal analysis for a possible Ozempic gallbladder injury case, there are other important factors also. Figuring out if there might be a drug injury lawsuit to file against Novo Nordisk for your gallbladder disease is not as simple as whether your gallbladder diagnosis was made before or after that March 2022 “line-in-the-sand” date.
Two important factors — having to do with things other than when your gallbladder disease was first diagnosed or when you had gallbladder removal surgery — are:
- What is the date (month/year) when your doctor prescribed Ozempic?
- Was that Ozempic prescription for one month, a few months, or one year?
Of course, there are additional facts we would consider when investigating these Ozempic gallbladder cases as possible drug injury cases.
Generally, the legal basis for these Ozempic gallbladder cases is that Novo Nordisk failed to warn doctors and patients about the risks of gallbladder diseases in a timely manner. The contention is that, when one views the March 2022 Ozempic drug label change in the context of what they knew and when they knew it, this Ozempic gallbladder disease warning should have been added earlier. For example, there are several medical journal articles published before 2022 that report the use of GLP-1 receptor agonists like Ozempic has been associated with an increased risk of bile duct and gallbladder diseases such as gallstones.
If we can be of assistance to you or someone you know, we encourage you to submit a Case Evaluation Form online. Attorney Tom Lamb will do your Ozempic gallbladder case review and get back to you no later than the next business day.
Or call us toll-free at (800) 426-9535 to speak directly to attorney Tom Lamb about a possible Ozempic gallbladder case.
Either way, you will get Mr. Lamb’s impressions about your Ozempic case based on his more than 20 years of experience handling drug injury lawsuits.[View article at original source]
Strictly Confidential, No Obligation